SecBot SecBot
DEFA14A ·Filed Apr 17, 2026

NMRA

Neumora Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed7mo ago SEC0001193125-26-161519
Proxy solicitation materials
Actionable Insight • Neutral

This is a standard annual shareholder meeting with no material financial impact. Shareholders should vote on the proposals, but no significant changes to company strategy or operations are expected.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$2.19
T+0 close · Apr 17, 2026 · via day close
Latest settled
−25.57%
T+60 · $1.63
Vs SPY
−32.35%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 20 $2.19entry
  2. T+1 · 7mo ago +5.94%α +6.59% · $2.32
  3. T+5 · 7mo ago +1.37%α +0.46% · $2.22
  4. T+20 · 6mo ago −19.18%α −23.38% · $1.77
  5. T+60 · 4mo ago −25.57%α −32.35% · $1.63
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Neumora Therapeutics, Inc. is holding its 2026 annual meeting of stockholders. The proxy statement outlines proposals for the election of three directors, ratification of the independent auditor, and advisory votes on executive compensation. This is a routine corporate governance filing.

Key Financial Metrics

Vote
director election
Meeting
2026-05-27
Seats Contested
3

Key Facts

  • Neumora Therapeutics, Inc. is holding its 2026 annual meeting of stockholders.
  • Proposals include the election of three Class III directors: Paul Berns, Matthew Fust, and David Piacquad.
  • Shareholders are asked to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm.
  • Advisory votes on the compensation of named executive officers and the frequency of future advisory votes are also on the agenda.

Financial Impact

Routine corporate governance matters; no direct financial impact.

Risk Factors

  • Failure to ratify the auditor could lead to delays in financial reporting, but this is highly unlikely.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-161519
Document: 0001193125-26-161519-index-headers.html0001193125-26-161519
Document: 0001193125-26-161519-index.html0001193125-26-161519
Document: 0001193125-26-161519.txt0001193125-26-161519

Track record

14 reports on NMRA

Performance horizon

3 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +77.33% at T+60 after the Aug 20, 2026 report. 5 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $0.3760 Now $0.3700 −1.60% settles Nov 24
  2. Nov 16, 2026today Press Release Neutral 4/10 Entry $0.4206 Now $0.3700 −12.03% settles Nov 23
  3. Oct 30, 202617d ago 8-K Bearish 7/10 Entry $0.4957 to $0.4859 Now $0.3700 +25.36% ▲ +1.98% +2.06% vs SPY
  4. Sep 22, 20267w ago Institutional Cluster Neutral 3/10 Entry $0.7785 to $0.6776 Now $0.3700 −52.47% ▼ −12.96% −11.77% vs SPY
  5. Aug 20, 202612w ago 144 Bearish 5/10 Entry $1.63 to $1.39 Now $0.3700 +77.30% ▲ +14.72% +15.20% vs SPY
  6. Aug 17, 202613w ago 144 Bearish 5/10 Entry $1.64 to $1.50 Now $0.3700 +77.44% ▲ +8.54% +8.34% vs SPY
  7. Aug 14, 202613w ago 8-K Neutral 4/10 No price data
  8. Aug 14, 202613w ago Press Release Neutral 4/10 Entry $1.60 to $1.63 Now $0.3700 −76.87% ▲ +1.88% +3.24% vs SPY
  9. Jul 27, 202616w ago 8-K Bullish 5/10 Entry $1.66 to $1.61 Now $0.3700 −77.71% ▼ −3.01% −4.09% vs SPY
  10. Jul 27, 202616w ago Press Release Bullish 7/10 Entry $1.66 to $1.61 Now $0.3700 −77.71% ▼ −3.01% −4.09% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 17, 2026